Targeting de novo purine biosynthesis for tuberculosis treatment靶向从头嘌呤生物合成以治疗结核病NatureIF48.52025-06-180OAAI
Macrocyclic Carbon-Linked Pyrazoles As Novel Inhibitors of MCL-1ACS MEDICINAL CHEMISTRY LETTERSIF42023-07-036OA
Discovery of an Oral, Beyond-Rule-of-Five Mcl-1 Protein-Protein Interaction Modulator with the Potential of Treating Hematological MalignanciesJOURNAL OF MEDICINAL CHEMISTRYIF6.82023-04-2810PRE
Divide and Conquer. Pocket-Opening Mixed-Solvent Simulations in the Perspective of Docking Virtual Screening Applications for Drug DiscoveryJOURNAL OF CHEMICAL INFORMATION AND MODELINGIF5.32022-01-185OA
Modulating physicochemical properties of tetrahydropyridine-2-amine BACE1 inhibitors with electron-withdrawing groups: A systematic studyEUROPEAN JOURNAL OF MEDICINAL CHEMISTRYIF5.92022-01-011PRE
A Brain-Penetrant and Bioavailable Pyrazolopiperazine BACE1 Inhibitor Elicits Sustained Reduction of Amyloid β In VivoACS MEDICINAL CHEMISTRY LETTERSIF42021-12-017OA
JNJ-67569762, A 2-Aminotetrahydropyridine-Based Selective BACE1 Inhibitor Targeting the S3 Pocket: From Discovery to Clinical CandidateJOURNAL OF MEDICINAL CHEMISTRYIF6.82021-09-2311PREAI
Development and implementation of an enterprise-wide predictive model for early absorption, distribution, metabolism and excretion propertiesFUTURE MEDICINAL CHEMISTRYIF3.42021-09-1615OA
Discovery of 3-({5-Chloro-1-[3-(methylsulfonyl)propyl]-1H-indol-2-yl}methyl)-1-(2,2,2-trifluoroethyl)-1,3-dihydro-2H-imidazo[4,5-c]pyridin-2-one (JNJ-53718678), a Potent and Orally Bioavailable Fusion Inhibitor of Respiratory Syncytial VirusJOURNAL OF MEDICINAL CHEMISTRYIF6.82020-05-1419PREAI
Preparation of 4′-Spirocyclobutyl Nucleoside Analogues as Novel and Versatile Adenosine ScaffoldsCHEMISTRY-A EUROPEAN JOURNALIF3.72019-11-0411PREAI
Evaluation of a Series of β-Secretase 1 Inhibitors Containing Novel Heteroaryl-Fused-Piperazine Amidine WarheadsACS MEDICINAL CHEMISTRY LETTERSIF42019-07-0227OAAI
Minisci-Photoredox-Mediated α-Heteroarylation of N-Protected Secondary Amines: Remarkable Selectivity of AzetidinesORGANIC LETTERSIF52018-09-2556PREAI
Synthesis and Evaluation of N-Phenyl-3-sulfamoyl-benzamide Derivatives as Capsid Assembly Modulators Inhibiting Hepatitis B Virus (HBV)JOURNAL OF MEDICINAL CHEMISTRYIF6.82018-06-1542PREAI
Fragment Binding to β-Secretase 1 without Catalytic Aspartate Interactions Identified via Orthogonal Screening ApproachesACS OMEGAIF4.32017-02-2414OAAI
1,4-Oxazine β-Secretase 1 (BACE1) Inhibitors: From Hit Generation to Orally Bioavailable Brain Penetrant LeadsJOURNAL OF MEDICINAL CHEMISTRYIF6.82015-10-1067OAAI
Molecular blueprint of allosteric binding sites in a homologue of the agonist-binding domain of the α7 nicotinic acetylcholine receptorΑ7烟碱型乙酰胆碱受体激动剂结合域同系物中变构结合位点的分子蓝图PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICAIF9.12015-04-2785OAAI
Structure-Based Site of Metabolism Prediction for Cytochrome P450 2D6JOURNAL OF MEDICINAL CHEMISTRYIF6.82011-08-0548PREAI
Molecular mechanisms of retroviral integrase inhibition and the evolution of viral resistancePROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICAIF9.12010-10-28295OAAI
1a/1b Subtype Profiling of Nonnucleoside Polymerase Inhibitors of Hepatitis C VirusJOURNAL OF VIROLOGYIF3.82010-03-1541OAAI